ÏÐÅÄÅËÍÈ ÖÅÍÈ ÍÀ ËÅÊÀÐÑÒÂÅÍÈ ÏÐÎÄÓÊÒÈ
(â ñèëà ñëåä 31 ÿíóàðè 2002 ã.)
"C"

Áåç ëåêàðñêî ïðåäïèñàíèå
Òúðãîâñêî íàèìåíîâàíèå/ëåê. Ôîðìà
è êîëè÷åñòâî íà àêòèâíîòî
âåùåñòâî â îêîí÷àòåëíà îïàêîâêà
Ðåã. No Ïðèòåæàòåë íà
àçðåøåíèåòî çà
óïîòðåáà
Êðàéíà
ïðîäàæíà
öåíà â ëâ.
Ìåæäóíàðîäíî íåïàòåíòíî
íàèìåíîâàíèå
No íà ðàçðåøåíèå
çà óïîòðåáà
ÄÂ,
áð./ãîä.
Calmaben tabl. coat. 50 mg x 10 R300009 Farmazeutische Fabrik Montavit Ges.m.b.H - Austria 6,48 Diphenhydramine II-9753/18.X.2004 ã. 008/2005
Calmaben tabl. coat. 50 mg x 20 R300010 Farmazeutische Fabrik Montavit Ges.m.b.H - Austria 3,56 Diphenhydramine II-9753/18.X.2004 ã. 008/2005
Cimicifugae rhizoma extr. sicc. R300080 Klimadynon tabl. film. 2,8 mg õ 60 15,00 Bionorica AG - Germany II-10893/26.05.2005 065/2005
Cocculus indicus 4 CH
Tabacum 4 CH
Nux vomica 4 CH
Petroleum 4 CH
R300048 Laboratoires Boiron - France 3,34 Cocculine tabl. õ 30 II-4544/19.12.2001 ã. 035/2005
Combination R300089 Revalid caps. õ 30 11,00 Ewopharma AG Switzerland 9808/18.10.2004 065/2005
Combination R300090 Revalid caps. õ 90 29,25 Ewopharma AG Switzerland 9808/18.10.2004 065/2005
Cytisine R300074 Tabex tabl. film. 1,5 mg õ 100 7,62 Ñîôàðìà - ÀÄ II-6268/06.11.2002 065/2005

Ïî ëåêàðñêî ïðåäïèñàíèå
Òúðãîâñêî íàèìåíîâàíèå Ðåã. No Ëåê. ôîðìà Ïðîèçâîäèòåë Çàÿâåíà öåíà íà
ïðîèçâîäèòåë, ëâ.
Öåíà íà òúðãîâåöà íà åäðî,
ëâ.
Öåíà íà òúðãîâåöà íà äðåáíî,
ëâ.
Öåíîâà
ãðóïà
ÄÂ/ãîä.
        öåíà ÄÄÑ îáùî ñ
ÄÄÑ
íàäö. öåíà ÄÄÑ îáùî ñ
ÄÄÑ
íàäö. öåíà ÄÄÑ îáùî ñ
ÄÄÑ
   
C - Film Lucchini R101881 vag. tabl.72 mg x 10 Laboratoire Lucchini S.A. 7.60 1.52 9.12 0.68 8.28 1.66 9.94 1.90 10.18 2.04 12.22 Â 17/2002
Cabergoline R105151 Cabaser tabl. 1 mgõ20 Pharmacia Italia SpA Italy 36,98 7,40 44,38 2,59 39,57 7,91 47,49 7,40 46,97 9,39 56,36 Ã 061/2004
Cabergoline R105152 Cabaser tabl. 2 mgõ20 Pharmacia Italia SpA Italy 73,42 14,68 88,11 5,14 78,56 15,71 94,27 14,68 93,25 18,65 111,89 Ã 061/2004
Cadexomer iodine R105194 Iodosorb Dressing dress. 5 g (6 cmõ 4 cm) õ5 Perstorp Pharma ­Sweden 65,13 13,03 78,15 4,56 69,69 13,94 83,63 13,03 82,71 16,54 99,26 Ã 075/2004
Cadexomer iodine R105195 Iodosorb Dressing dress. 10 g (8 cmõ 6 cm)õ3 Perstorp Pharma ­Sweden 78,17 15,63 93,81 5,47 83,65 16,73 100,38 15,63 99,28 19,86 119,14 Ã 075/2004
Caelyx conc. inf. 2 mg/ml ­ 10ml R103863 conc. inf. Schering- Plough Labo N.V. 1055,03 211,01 1266,04 15,00 1070,03 214,01 1284,04 30,00 1100,03 220,01 1320,04 Ã 039/2002
Caelyx conc. inf. 2 mg/ml ­ 25ml R103864 conc. inf. Schering- Plough Labo N.V. 2542,58 508,52 3051,09 15,00 2557,58 511,52 3069,09 30,00 2587,58 517,52 3105,09 Ã 039/2002
Caffeine R201379 Coffeinum ­ Natrio benzoicum sol. inj. 200 mg/ml ­ 1 ml õ 10 Ñîôàðìà ­ ÀÄ 6,90 1,38 8,28 0,69 7,59 1,52 9,11 1,93 9,52 1,90 11,43 Á 066/2004
Caffeine R201380 Coffeinum- Natrio benzoicum sol. inj. 200 mg/ml ­ 1 ml õ 100 Ñîôàðìà ­ ÀÄ 69,00 13,80 82,80 4,83 73,83 14,77 88,60 13,80 87,63 17,53 105,16 Ã 066/2004
Calciton 200 spray nas. 200IU/ dose ­ õ 14 doses R104378 spray nas. Slovakofarma a.s. 80,19 16,04 96,23 5,61 85,80 17,16 102,96 16,04 101,84 20,37 122,21 Ã 013/2003
Calciton 200 spray nas. 200IU/dose ­ õ 28 doses R104379 spray nas. Slovakofarma a.s. 160,38 32,08 192,45 11,23 171,60 34,32 205,93 30,00 201,60 40,32 241,93 Ã 013/2003
Calcitonin (salmon synthetic) R105399 Miacalcic sol. inj. 50 IU/ml - 1 ml x 5 Novartis Pharma Services Inc. Switzerland 24,33 4,87 29,20 2,19 26,52 5,30 31,82 6,08 32,60 6,52 39,12 Á 008/2005
Calcitonin (salmon synthetic) R105400 Miacalcic sol. inj. 100 IU/ml - Novartis Pharma Services Inc. Switzerland 45,67 9,13 54,80 3,20 48,87 9,77 58,64 9,13 58,00 11,60 69,60 Â 008/2005
Calcitonin 100 - 5 R103427 sol. for injection STADA Arzneimittel AG 24.28 4.86 29.13 2.18 26.46 5.29 31.75 6.07 32.53 6.51 39.03 Â 17/2002
Calcitonin 100 Stada - 20 R103428 sol. for injection STADA Arzneimittel AG 95.42 19.08 114.50 6.68 102.10 20.42 122.52 19.08 121.18 24.24 145.42 Ã 17/2002
Calcitonin 50 Stada - 20 R103426 sol. for injection STADA Arzneimittel AG 81.48 16.30 97.78 5.70 87.19 17.44 104.62 16.30 103.48 20.70 124.18 Ã 17/2002
Calcitonin 50 Stada 5 R103425 sol. for injection STADA Arzneimittel AG 19.42 3.88 23.30 1.75 21.16 4.23 25.40 4.85 26.02 5.20 31.22 Â 17/2002
Calcium - sandoz 500 mg x 10 R102365 eff. tabl. Novartis Consumer Health SA Nyon 4.38 0.88 5.26 0.44 4.82 0.96 5.79 1.23 6.05 1.21 7.26 Á 17/2002
Calcium folinate R105508 Leucovorin Ca Lachema 10 powd.inj./inf. 10mg õ 10 Pliva-Lachema A.S. ­ Czech Republic 36,20 7,24 43,44 2,53 38,74 7,75 46,48 7,24 45,98 9,20 55,17 Â 023/2005
Calcium Folinate Stada sol.inj. 12,7 mg/ml 10 ml R104281 sol.inj. Cell pharm GmbH 15,06 3,01 18,07 1,36 16,42 3,28 19,70 3,76 20,18 4,04 24,22 Â 100/2002
Calcium Folinate Stada sol.inj. 12,7 mg/ml 20 ml R104282 sol.inj. Cell pharm GmbH 25,62 5,12 30,75 2,31 27,93 5,59 33,51 6,41 34,33 6,87 41,20 Â 100/2002
Calcium Folinate Stada sol.inj. 12,7 mg/ml 50 ml R104283 sol.inj. Cell pharm GmbH 64,54 12,91 77,45 4,52 69,06 13,81 82,87 12,91 81,97 16,39 98,36 Ã 100/2002
Calcium Folinate Stada sol.inj. 12.7 mg/ml 100 ml R104284 sol.inj. Cell pharm GmbH 116,18 23,24 139,41 8,13 124,31 24,86 149,17 23,24 147,54 29,51 177,05 Ã 100/2002
Calcium gluconate Calcium laevulate R201319 Calcium Gluconicum sol. inj. 8,94 mg/ml ­ 10 ml x 5 Ñîôàðìà ­ ÀÄ 7,65 1,53 9,18 0,69 8,34 1,67 10,01 1,91 10,25 2,05 12,30 Â 033/2004
Calcium gluconate Calcium laevulate R201320 Calcium Gluconicum sol. inj. 8,94 mg/ml ­ 10 ml x 50 Ñîôàðìà ­ ÀÄ 76,50 15,30 91,80 5,36 81,86 16,37 98,23 15,30 97,16 19,43 116,59 Ã 033/2004
CALCIUM GLUCONICUM 8,94 mg/ml - 10 ml õ 50 R200362 sol.inj. Ñîôàðìà - ÀÄ 50,00 10,00 60,00 3,50 53,50 10,70 64,20 10,00 63,50 12,70 76,20 Ã 12/2002
Calcium Gluconicum tabl. eff. 2000 mg õ 10 R200926 tabl. eff. Áàëêàíôàðìà­ Äóïíèöà ­ ÀÄ 1,68 0,34 2,02 0,17 1,85 0,37 2,22 0,47 2,32 0,46 2,78 Á 019/2003
Calcium gluconicum tabl. eff. õ 10 R200559 tabl. Áàëêàíôàðìà - Äóïíèöà - ÀÄ 1,29 0,26 1,55 0,13 1,42 0,28 1,70 0,36 1,78 0,36 2,14 Á 12/2002
Calcium gluconicum8,94 mg/ml ­10 mlõ50 R201017 sol.inj. Ñîôàðìà ­ ÀÄ 64,00 12,80 76,80 4,48 68,48 13,70 82,18 12,80 81,28 16,26 97,54 Ã 019/2003
Calcium hydrogen phosphate; Calcium lactate; Calcium glycerophosphate; Ascorbic acid R201198 Calcium Phospho C tabl. film.õ30 Ñîôàðìà ­ ÀÄ 2,20 0,44 2,64 0,22 2,42 0,48 2,90 0,62 3,04 0,61 3,64 Á 019/2004
CALCIUM PHOSPHO C õ 10 R200404 film.tabl. Ñîôàðìà - ÀÄ 0,39 0,08 0,47 0,05 0,44 0,09 0,52 0,13 0,57 0,11 0,68 Á 12/2002
CALCIUM PHOSPHO C õ 30 R200405 film.tabl. Ñîôàðìà - ÀÄ 1,50 0,30 1,80 0,15 1,65 0,33 1,98 0,42 2,07 0,41 2,48 Á 12/2002
Calcium phospho Ñõ30 R201024 film. tabl. Ñîôàðìà ­ ÀÄ 1,92 0,38 2,30 0,19 2,11 0,42 2,53 0,54 2,65 0,53 3,18 Á 019/2003
Calcium Upsavit 500 mg x 20 eff.tabl. R100881 eff.tabl. Bristol-Myers Squibb Co. 2.49 0.50 2.99 0.25 2.74 0.55 3.29 0.70 3.44 0.69 4.13 Á 17/2002
Calciumfolinat "Ebewe" 10 mg / ml - 10 ml x 5 R101108 sol. inj. Ebewe Arzneimittel GmbH 141.40 28.28 169.68 9.90 151.30 30.26 181.56 28.28 179.58 35.92 215.49 Ã 17/2002
Calciumfolinat "Ebewe" 10 mg / ml - 3 ml x 5 R101106 sol. inj. Ebewe Arzneimittel GmbH 56.56 11.31 67.87 3.96 60.52 12.10 72.62 11.31 71.83 14.37 86.19 Ã 17/2002
Calciumfolinat "Ebewe" 15 mg x 20 R101107 caps. Ebewe Arzneimittel GmbH 56.56 11.31 67.87 3.96 60.52 12.10 72.62 11.31 71.83 14.37 86.19 Ã 17/2002
Calciumfolinat "Ebewe" 3 mg / ml - 1 ml x 10 R101105 sol. inj. Ebewe Arzneimittel GmbH 25.45 5.09 30.54 2.29 27.74 5.55 33.29 6.36 34.10 6.82 40.92 Â 17/2002
Calciumfolinate "EBEWE" 10 mg/ml ­ 3 ml õ 5 R103891 sol.inj. EBEWE Arzneimittel GmbH 56,80 11,36 68,16 3,98 60,78 12,16 72,93 11,36 72,14 14,43 86,56 Ã 073/2002
Calciumfolinate "EBEWE" 15 mg õ 20 R103892 caps. EBEWE Arzneimittel GmbH 56,80 11,36 68,16 3,98 60,78 12,16 72,93 11,36 72,14 14,43 86,56 Ã 073/2002
Calciumfolinate "EBEWE" 3 mg/ml ­ 1 ml õ 10 R103890 sol.inj. EBEWE Arzneimittel GmbH 25,56 5,11 30,67 2,30 27,86 5,57 33,43 6,39 34,25 6,85 41,10 Â 073/2002
Calciumfolinate "EBEWE"10 mg/ml ­ 5 mlõ5 R103886 sol. inj. EBEWE Arzneimittel GmbH 85,20 17,04 102,24 5,96 91,16 18,23 109,40 17,04 108,20 21,64 129,84 Ã 039/2002
Calgel 10 g R101475 gel Glaxo Wellcome 3.79 0.76 4.55 0.38 4.17 0.83 5.01 1.06 5.23 1.05 6.28 Á 17/2002
Calgevax, 37,5 mg R200176 powd.irr. Áóë Áèî - ÍÖÇÏÁ 13,44 2,69 16,13 1,21 14,65 2,93 17,58 3,36 18,01 3,60 21,61 Â 12/2002
Callergin syr. 125 ml R200680 syr. Áàëêàíôàðìà -Òðîÿí - ÀÄ 1,20 0,24 1,44 0,12 1,32 0,26 1,58 0,34 1,66 0,33 1,99 Á 12/2002
Callergin syr. 125 ml R200895 syr. Áàëêàíôàðìà­ Òðîÿí ­ ÀÄ 1,80 0,36 2,16 0,18 1,98 0,40 2,38 0,50 2,48 0,50 2,98 Á 019/2003
Calpol 6+250 mg / 100 ml R101477 susp. Glaxo Wellcome 4.42 0.88 5.30 0.44 4.86 0.97 5.83 1.24 6.10 1.22 7.31 Á 17/2002
Calpol infant120 mg / 100 ml R101476 susp. Glaxo Wellcome 3.20 0.64 3.84 0.32 3.52 0.70 4.22 0.90 4.42 0.88 5.30 Á 17/2002
Calypsol 10 ml x 5 R100910 inj. Chemical works of Gedeon Richter ltd. 36.58 7.32 43.89 2.56 39.14 7.83 46.96 7.32 46.45 9.29 55.74 Ã 17/2002
Camphorae spiritus 0,8 kgl R200096 sol. ÅÒ Õèìàêñ 4,36 0,87 5,23 0,44 4,80 0,96 5,76 1,22 6,02 1,20 7,22 Á 12/2002
Camphorae spiritus100 ml R200095 sol. ÅÒ Õèìàêñ 0,56 0,11 0,67 0,07 0,63 0,13 0,75 0,18 0,81 0,16 0,97 À 12/2002
Campto Powd. Inj. 100 mg x 1 R102946 powd. Inj. Rhone-Poulenc Rorer 515.86 103.17 619.03 15.00 530.86 106.17 637.03 30.00 560.86 112.17 673.03 Ã 17/2002
Campto Powd. Inj. 40 mg x 1 R102945 powd. Inj. Rhone-Poulenc Rorer 207.26 41.45 248.71 14.51 221.77 44.35 266.12 30.00 251.77 50.35 302.12 Ã 17/2002
Cancidas powd. conc. inf. 50 mg õ 1 R104302 powd. conc. inf. Merck Sharp & Dohme B.V. 833,91 166,78 1000,69 15,00 848,91 169,78 1018,69 30,00 878,91 175,78 1054,69 Ã 106/2002
Cancidas powd. conc. inf. 50 mg õ 1 R104473 powd. conc. inf. Merck Sharp& Dohme B.V. 934,89 186,98 1121,86 15,00 949,89 189,98 1139,86 30,00 979,89 195,98 1175,86 Ã 019/2003
Cancidas powd. conc. inf. 70 mg õ 1 R104303 powd. conc. inf. Merck Sharp & Dohme B.V. 1087,44 217,49 1304,93 15,00 1102,44 220,49 1322,93 30,00 1132,44 226,49 1358,93 Ã 106/2002
Cancidas powd. conc. inf. 70 mg õ 1 R104474 powd. conc. inf. Merck Sharp& Dohme B.V. 1189,14 237,83 1426,97 15,00 1204,14 240,83 1444,97 30,00 1234,14 246,83 1480,97 Ã 019/2003
Canesten 20g cream R100374 spray BAYER AG 4.56 0.91 5.47 0.46 5.01 1.00 6.02 1.28 6.29 1.26 7.55 Á 17/2002
Canesten 20ml solutio R100375 sol. BAYER AG 4.56 0.91 5.47 0.46 5.01 1.00 6.02 1.28 6.29 1.26 7.55 Á 17/2002
Canesten 30g pawder R100377 spray BAYER AG 4.90 0.98 5.88 0.49 5.39 1.08 6.47 1.37 6.76 1.35 8.11 Á 17/2002
Canesten Gyn 3 tabl. vag. 200 mg õ 3+3 applicators R104247 tabl. vag. Bayer AG 6,73 1,35 8,07 0,67 7,40 1,48 8,88 1,88 9,28 1,86 11,14 Á 095/2002
Canesten30ml spray R100376 spray BAYER AG 5.10 1.02 6.12 0.51 5.61 1.12 6.73 1.43 7.04 1.41 8.45 Á 17/2002
Captopril ­ Egis tabl. 12,5 mg õ 30 R104345 tabl. Egis Pharmaceuticals 1,29 0,26 1,55 0,13 1,42 0,28 1,70 0,36 1,78 0,36 2,14 Á 113/2002
Captopril ­ Egis tabl. 25 mg õ 30 R104346 tabl. Egis Pharmaceuticals 1,60 0,32 1,92 0,16 1,76 0,35 2,12 0,45 2,21 0,44 2,66 Á 113/2002
Captopril ­ Egis tabl. 50 mg õ 20 R104347 tabl. Egis Pharmaceuticals 1,94 0,39 2,32 0,19 2,13 0,43 2,56 0,54 2,67 0,53 3,21 Á 113/2002
CAPTOPRIL 25 mg õ 40 R200406 tabl. Ñîôàðìà - ÀÄ 1,21 0,24 1,45 0,12 1,33 0,27 1,60 0,34 1,67 0,33 2,00 Á 12/2002
Captopril tabl. 12,5 mg õ 60 R200153 tabl. ÍÈÕÔÈ - ÀÄ 1,9 0,38 2,28 0,19 2,09 0,42 2,51 0,53 2,62 0,52 3,15 Á 12/2002
Captopril25 mgõ40 R201025 tabl. Ñîôàðìà ­ ÀÄ 1,55 0,31 1,86 0,16 1,71 0,34 2,05 0,43 2,14 0,43 2,57 Á 019/2003
Carbamazepin tabl. 200 mg õ 50 R200560 tabl. Áàëêàíôàðìà - Äóïíèöà - ÀÄ 6,25 1,25 7,50 0,63 6,88 1,38 8,25 1,75 8,63 1,73 10,35 Á 12/2002
Carbamazepine R104651 Neurotop tabl. 200 mg õ 50 Gerot Pharmazeutika GmbH Austria 6,65 1,33 7,98 0,66 7,31 1,46 8,78 1,86 9,18 1,84 11,01 Á 104/2003
Carbamazepine R104961 Stazepine tabl. 200 mg x 50 Pharmaceutical Works PolpharmaS.A. Poland 5,63 1,13 6,76 0,56 6,20 1,24 7,44 1,58 7,77 1,55 9,33 Á 033/2004
Carbamide R104387 Linola Urea cream 12 % ­ 75 g Dr. August Wolff GmbH & Co.Arzneimittel ­ Germany 10,07 2,01 12,09 0,91 10,98 2,20 13,17 2,52 13,50 2,70 16,20 Â 073/2003
Carbasan 200 mg. X 50 R102994 tabl. Sanofi 10.43 2.09 12.51 0.94 11.36 2.27 13.64 2.61 13.97 2.79 16.76 Â 17/2002
Carbo activatus 250 mg x 20 R103721 tabl. ÇÀÎ Ìåäèñîðá 1.59 0.32 1.91 0.16 1.75 0.35 2.10 0.45 2.20 0.44 2.64 Á 17/2002
Carbocisteine R105557 HUMEXCOUGH ADULTS SYRUP syrup 5 g/100 ml - 125 ml Laboratoires URGO - France 3,87 0,77 4,65 0,39 4,26 0,85 5,11 1,08 5,34 1,07 6,41 A 039/2005
Carbocisteine R105558 HUMEXCOUGH CHILDREN 2 % SYRUP syrup 2 g/100 ml - 125 ml Laboratoires URGO - France 3,03 0,61 3,64 0,30 3,33 0,67 4,00 0,85 4,18 0,84 5,02 A 039/2005
Carbophos x 40 R100839 tabl. sol. Bristol-Myers Squibb Co. 2.64 0.53 3.17 0.26 2.91 0.58 3.49 0.74 3.65 0.73 4.37 Á 17/2002
Carboplatin R105509 Cycloplatin 50 powd. inf. 50 mg õ 10 Pliva-Lachema A.S. ­ Czech Republic 188,33 37,67 225,99 13,18 201,51 40,30 241,81 30,00 231,51 46,30 277,81 Â 023/2005
Carboplatin R105510 Cycloplatin 200 powd. inf. 200 mg õ 5 Pliva-Lachema A.S. ­ Czech Republic 286,29 57,26 343,55 15,00 301,29 60,26 361,55 30,00 331,29 66,26 397,55 Â 023/2005
Carboplatin "EBEWE" 10 mg/ml ­ 15 ml õ 1 R103894 conc. inf. EBEWE Arzneimittel GmbH 128,37 25,67 154,04 8,99 137,35 27,47 164,82 25,67 163,03 32,61 195,63 Ã 073/2002
Carboplatin "EBEWE" 10 mg/ml ­ 45 ml õ 1 R103895 conc. inf. EBEWE Arzneimittel GmbH 174,23 34,85 209,08 12,20 186,43 37,29 223,72 30,00 216,43 43,29 259,72 Ã 073/2002
Carboplatin "EBEWE" 10 mg/ml ­ 5 ml õ 1 R103893 conc. inf. EBEWE Arzneimittel GmbH 53,25 10,65 63,90 3,73 56,98 11,40 68,37 10,65 67,63 13,53 81,15 Ã 073/2002
Carboplatin "Ebewe"10 mg / ml - 15 ml R101088 conc. inf. Ebewe Arzneimittel GmbH 127.83 25.57 153.39 8.95 136.77 27.35 164.13 25.57 162.34 32.47 194.81 Ã 17/2002
Carboplatin "Ebewe"10 mg / ml - 45 ml R101087 conc. inf. Ebewe Arzneimittel GmbH 212.10 42.42 254.52 14.85 226.95 45.39 272.34 30.00 256.95 51.39 308.34 Ã 17/2002
Carboplatin "Ebewe"10 mg / ml - 5 ml R101086 conc. inf. Ebewe Arzneimittel GmbH 53.03 10.61 63.63 3.71 56.74 11.35 68.08 10.61 67.34 13.47 80.81 Ã 17/2002
Carboplatin 10 mg / ml - 15 ml R100020 sol. inj. Abic - Teva Group 97.10 19.42 116.52 6.80 103.90 20.78 124.68 19.42 123.32 24.66 147.98 Ã 17/2002
Carboplatin 10 mg / ml - 45 ml R100019 sol. inj. Abic - Teva Group 189.98 38.00 227.98 13.30 203.28 40.66 243.94 30.00 233.28 46.66 279.94 Ã 17/2002
Carboplatin 10 mg / ml - 5 ml R100018 sol. inj. Abic - Teva Group 38.00 7.60 45.60 2.66 40.66 8.13 48.79 7.60 48.26 9.65 57.91 Ã 17/2002
Carboplatin 10 mg / ml inj 15 ml pl R102690 fl. Pharmacia Upjohn 46.33 9.27 55.60 3.24 49.58 9.92 59.49 9.27 58.84 11.77 70.61 Ã 17/2002
Carboplatin 10 mg / ml inj 5 ml pl R102691 fl. Pharmacia Upjohn 22.86 4.57 27.43 2.06 24.92 4.98 29.90 5.71 30.63 6.13 36.76 Â 17/2002
Cardioxan 50 mg R100960 fl. Chiron B.V - Netherlands 253.31 50.66 303.97 15.00 268.31 53.66 321.97 30.00 298.31 59.66 357.97 Ã 17/2002
Cardiplant80 mg õ 50 R103765 film. tabl. Dr.Willmar Schwabe GmbH & Co 7,63 1,53 9,15 0,69 8,31 1,66 9,98 1,91 10,22 2,04 12,27 Â 28/2002
Cardura 1mgx30 R102632 tabl. Pfizer 26.91 5.38 32.29 2.42 29.33 5.87 35.20 6.73 36.06 7.21 43.27 Â 17/2002
Cardura 2mgx30 R102633 tabl. Pfizer 30.94 6.19 37.13 2.17 33.11 6.62 39.73 6.19 39.30 7.86 47.16 Ã 17/2002
Cardura 4mgx30 R102634 tabl. Pfizer 39.00 7.80 46.80 2.73 41.73 8.35 50.08 7.80 49.53 9.91 59.44 Ã 17/2002
Carminativum Babynos Colic drops - 30 ml R101026 drops. Dentinox KG - Germany 3.02 0.60 3.62 0.30 3.32 0.66 3.98 0.84 4.16 0.83 5.00 Á 17/2002
Carminativum Babynos colic drops 30 ml R103745 drops Dentinox 3,07 0,61 3,68 0,31 3,38 0,68 4,05 0,86 4,24 0,85 5,09 Á 21/2002
Carmolis 40 ml R101074 drops. Dr.A&L.Schmidgall 3.41 0.68 4.09 0.34 3.75 0.75 4.50 0.95 4.70 0.94 5.64 Á 17/2002
Carmolis 80 ml R101075 drops. Dr.A&L.Schmidgall 4.08 0.82 4.90 0.41 4.49 0.90 5.39 1.14 5.64 1.13 6.76 Á 17/2002
Carmolis drops/sol.cut./ sol.inh. ­ 40 ml R104262 drops/sol.cut. /sol. inh. Dr. A.& L.Schmidgall 3,34 0,67 4,01 0,33 3,68 0,74 4,41 0,94 4,62 0,92 5,54 Á 100/2002
Carmolis drops/sol.cut./sol.inh. ­80 ml R104263 drops/sol.cut. /sol. inh. Dr. A.& L.Schmidgall 4,01 0,80 4,81 0,40 4,41 0,88 5,29 1,12 5,53 1,11 6,64 Á 100/2002
Carsil 100 mg õ 30 R201044 caps. Ñîôàðìà ­ ÀÄ 5,70 1,14 6,84 0,57 6,27 1,25 7,52 1,60 7,87 1,57 9,44 Á 017/2003
CARSIL 35 mg õ 80 R200407 coat.tabl. Ñîôàðìà - ÀÄ 2,70 0,54 3,24 0,27 2,97 0,59 3,56 0,76 3,73 0,75 4,47 Á 12/2002
Carvedilol R105665 Coryol tablet 3,125 mg x 28 KRKA - Slovenia 3,81 0,76 4,58 0,38 4,20 0,84 5,03 1,07 5,26 1,05 6,32 À 065/2005
Casodex 50 mg x 28 R100199 tabl. AstraZeneca 363.08 72.62 435.69 15.00 378.08 75.62 453.69 30.00 408.08 81.62 489.69 Ã 17/2002
Cataflam 25 mg x 20 R102408 SC tabl. Novartis Pharma Services Inc. 3.73 0.75 4.47 0.37 4.10 0.82 4.92 1.04 5.14 1.03 6.17 Á 17/2002
Cataflam 50 mg x 10 R102409 SC tabl. Novartis Pharma Services Inc. 3.34 0.67 4.01 0.33 3.68 0.74 4.41 0.94 4.61 0.92 5.53 Á 17/2002
Catalin - 15 ml R103481 drops Takeda 6.83 1.37 8.19 0.68 7.51 1.50 9.01 1.91 9.42 1.88 11.30 Á 17/2002
Cathejell with lidocain gel ureth 12,5 g õ 25 R104482 gel ureth Fharmazeutische Fabrik Montavit 54,76 10,95 65,72 3,83 58,60 11,72 70,32 10,95 69,55 13,91 83,46 Ã 019/2003
Cathejell with lidocain gel ureth 8,5 g õ 25 R104293 gel ureth Fharmaceutische Fabrik Montavit Ges.m.b.H 43,03 8,61 51,63 3,01 46,04 9,21 55,25 8,61 54,65 10,93 65,58 Ã 106/2002
Cathejell with lidocaine 12.5 mg x 25 tubes R102167 urethral gel Montavit GmbH 49.75 9.95 59.70 3.48 53.23 10.65 63.88 9.95 63.18 12.64 75.82 Ã 17/2002
Caverject 10 mcg s.po. amp. ad es 2 sw R102692 amp. Pharmacia Upjohn 21.11 4.22 25.33 1.90 23.01 4.60 27.61 5.28 28.29 5.66 33.94 Â 17/2002
Caverject 20 mcg s.po. amp. ad es 2 sw R102693 amp. Pharmacia Upjohn 29.55 5.91 35.46 2.66 32.21 6.44 38.65 7.39 39.60 7.92 47.52 Â 17/2002
Cavinton 2 ml x 10 R100911 inj. Chemical works of Gedeon Richter ltd. 12.92 2.58 15.50 1.16 14.08 2.82 16.90 3.23 17.31 3.46 20.77 Â 17/2002
Cavinton Forte 10 mg õ 30 R104029 tabl. Gedeon Richter Ltd. 9,58 1,92 11,50 0,86 10,45 2,09 12,54 2,40 12,84 2,57 15,41 Â 066/2002
Cavinton Forte 10 mg õ 90 R104030 tabl. Gedeon Richter Ltd. 27,38 5,48 32,86 2,46 29,85 5,97 35,82 6,85 36,69 7,34 44,03 Â 066/2002
Cavinton x 50 R100912 tabl. Chemical works of Gedeon Richter ltd. 8.53 1.71 10.23 0.77 9.29 1.86 11.15 2.13 11.42 2.28 13.71 Â 17/2002
CCNU 40 mg x 20 R100813 tabl. Bristol-Myers Squibb Co. 255.49 51.10 306.59 15.00 270.49 54.10 324.59 30.00 300.49 60.10 360.59 Ã 17/2002
CEC 125mg/5 ml-100ml R101599 powd. for oral susp. Hexal AG 11.38 2.28 13.66 1.02 12.41 2.48 14.89 2.85 15.25 3.05 18.30 Â 17/2002
CEC 250, 250 mg X 10 R101597 eff.tabl. Hexal AG 11.59 2.32 13.91 1.04 12.63 2.53 15.16 2.90 15.53 3.11 18.64 Â 17/2002
CEC 500, 500 mg X 10 R101598 eff.tabl. Hexal AG 19.46 3.89 23.35 1.75 21.21 4.24 25.45 4.86 26.07 5.21 31.29 Â 17/2002
CEC forte 250mg/5ml-100ml R101600 powd. for oral susp. Hexal AG 22.96 4.59 27.55 2.07 25.02 5.00 30.03 5.74 30.76 6.15 36.92 Â 17/2002
Ceclor 125 mg / 5 ml, 75 ml R101195 susp. Eli Lilly 13.00 2.60 15.60 1.17 14.17 2.83 17.00 3.25 17.42 3.48 20.90 Â 17/2002
Ceclor 250 mg / 5 ml R101196 susp. Eli Lilly 26.01 5.20 31.21 2.34 28.35 5.67 34.02 6.50 34.85 6.97 41.82 Â 17/2002
Ceclor 250 mg x 15 R101197 caps. Eli Lilly 23.75 4.75 28.50 2.14 25.89 5.18 31.07 5.94 31.83 6.37 38.19 Â 17/2002
Ceclor 500 mg x 15 R101198 caps. Eli Lilly 47.49 9.50 56.99 3.32 50.82 10.16 60.98 9.50 60.31 12.06 72.38 Ã 17/2002
Ceclor MR 375 mg x 10 R103767 tabl. prolong Eli Lilly Italia S.p.A. 14,32 2,86 17,18 1,29 15,61 3,12 18,73 3,58 19,18 3,84 23,02 Â
Ceclor MR 500 mg x 10 R103768 tabl. prolong Eli Lilly Italia S.p.A. 18,64 3,73 22,37 1,68 20,32 4,06 24,38 4,66 24,98 5,00 29,97 Â
Cedax(r) 30 ml, 36 mg / ml R103087 powder for susp. Schering - Plough USA 22.69 4.54 27.23 2.04 24.73 4.95 29.68 5.67 30.41 6.08 36.49 Â 17/2002
Cedax(r) 400 mg x 5 R103086 caps. Schering - Plough USA 37.78 7.56 45.34 2.64 40.43 8.09 48.51 7.56 47.98 9.60 57.58 Ã 17/2002
Cedigalan 10 ml 1 mg/ml R103713 sol Zdravlje - Leskovac 2.13 0.43 2.56 0.21 2.35 0.47 2.82 0.60 2.94 0.59 3.53 Á 17/2002
Cedigalan 20 x 0.25 mg R103711 tabl Zdravlje - Leskovac 0.81